Wayne State University
Head and neck cancer survivors at high risk for second primary lung cancer
Survivors of head and neck cancer appeared at increased risk for a second primary lung cancer, according to results of an ad hoc secondary analysis of a randomized trial published in JAMA Otolaryngology-Head & Neck Surgery.
Association of Community Cancer Centers names Innovator Award recipients
Devimistat regimen fails to extend OS in metastatic pancreatic cancer
Devimistat plus a modified standard-of-care chemotherapy regimen failed to extend OS among patients with metastatic pancreatic cancer, according to results of the randomized phase 3 AVENGER 500 trial released by the agent’s manufacturer.
Adjunctive perampanel effective in older patients with focal-onset seizures
Long-term adjunctive perampanel treatment was efficacious and generally well tolerated among older patients with focal-onset seizures, according to findings presented at the annual meeting of the American Neurological Association.
Uplizna effective, safe for African Americans with neuromyelitis optica spectrum disorder
Horizon Therapeutics plc announced results of a retrospective analysis that showed Uplizna appeared to offer durable efficacy and a favorable safety profile for African American patients with neuromyelitis optica spectrum disorder.
Opioid prescription laws provide ‘significant but limited outcome’
Laws in 23 states that capped the number of days a Medicare enrollee could receive an initial opioid prescription may have had their intended effect, a recent study showed.
Health care providers urged to create 'culturally safe medical home' for patients
Understanding the parameters of bias, race and racism is critical to creating an environment in which patients of all backgrounds feel comfortable, according to the keynote speaker at the 2021 Rheumatology Nurses Society annual conference.
Metabolic syndrome ‘better prognostic indicator’ for severe COVID-19 outcomes
Odds for severe COVID-19 outcomes were increased for patients with metabolic syndrome, , according to a study published in the Journal of Diabetes.
Failure to initiate TKIs linked to higher inpatient costs for older patients with CML
Approximately 29% of older patients with chronic myeloid leukemia did not initiate tyrosine kinase inhibitor therapy within 6 months of diagnosis, according to study results published in Journal of Clinical Oncology.
Tumor-infiltrating lymphocytes plus pembrolizumab active in metastatic HNSCC
The combination of an investigational cell therapy using tumor-infiltrating lymphocytes and pembrolizumab induced responses among a small cohort of patients with metastatic head and neck squamous cell carcinoma, study results showed.